Ethema Health Corp (GRST)

[Bubae]

Sure, it is very common for OTC companies to fund their operations through toxic financing. However, This stock has a real debt problem still and is unable to help with only about $119K in net earnings. Ethema (GRST) has dropped 509.5 million new shares in Q3 and have converted 432 million new shares so far for Q4 with a month left in the quarter. A little over 1.5 billion new shares so far for 2021. LABRYS has two of its financing notes that will need around 1.3 billion shares to settle the obligation in the next 5 months. May as well say 600 plus million new shares per quarter at the current trading price of .0012. That is just for the LABRYS fund and doesn't account for all of LABRYS eligible debt conversions.

This stock isn't generating any volume and interest because of the conversions in place and after months of hyping the ARIA purchase it only generated an additional $53k in net earnings for the quarter. The cash flow is so bad that they continue to finance the operation through additional debt for equity offerings.

So do they do another of their biannual refinance deals and PR coming? Even if they do this ticker still has a real problem with debt. If they let the debt go ahead and convert through Q2, 2022 then in my opinion the reverse split is all but locked in.


https://www.otcmarkets.com/filing/html?id=15373092&guid=o6ywkeoFaVw-B3h

Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,111,047,811 and 2,027,085,665 shares of common stock at September 30, 2021 and December 31, 2020, respectively.



https://www.otcmarkets.com/filing/html?id=15373092&guid=55ywkew26hwfJth

Revenues $ 866,432 Period ended September, 31 operating income $118,964.

https://sec.report/Document/0001721868-21-000524/

Revenues $ 96,158 Period ended June, 30 operating income $65,554


ETHEMA HEALTH CORPORATION
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
13. Short term loans (continued)

"On April 29, 2021, the Company, entered into a secured Promissory Note in the aggregate principal amount of $46,000 for net proceeds of $40,000 after an original issue discount of $6,000. The Note had a maturity date of May 3, 2021 and bore interest at the rate of zero percent per annum from the date on which the Note was issued until the same became due and payable."

The Company repaid the note on May 3, 2021 for $46,000.

"On April 30, 2021, the Company, entered into a secured Promissory Note in the aggregate principal amount of $140,000 for net proceeds of $126,000 after an original issue discount of $14,000. The Note had a maturity date of May 7, 2021 and bore interest at the rate of zero percent per annum from the date on which the Note was issued until the same became due and payable."

The Company repaid the note on May 10, 2021 for $140,000.

"On May 27, 2021, the Company, entered into a secured Promissory Note in the aggregate principal amount of $70,000 for net proceeds of $60,000 after an original issue discount of $10,000. The Note had a maturity date of June 4, 2021 and bore interest at the rate of zero percent per annum from the date on which the Note was issued until the same became due and payable."

The Company repaid the note on June 4, 2021 for $70,000.

"On September 15, 2021, the Company, entered into a secured Promissory Note in the aggregate principal amount of $60,000 for net proceeds of $50,000 after an original issue discount of $10,000. The Note had a maturity date of September 23, 2021 and bears interest at the rate of zero percent per annum from the date on which the Note was issued until the same became due and payable."

The note was still outstanding at September 30, 2021.


23. Subsequent events


“On October 1, 2021, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued a Convertible Promissory Note in the aggregate principal amount of $95,200, for net proceeds of $85,000 before the payment of legal fees and origination fees amounting to $3,750. The note has a maturity date of October 1, 2022 and bears interest at the rate of 8.0% due immediately on the issuance ate of the note. per annum. The outstanding principal amount of the note is payable in nine monthly payments of $11,424 commencing on November 15, 2021. The note is convertible into shares of common stock upon an event of default at the election of the purchaser. The conversion price is 75% of the lowest trading price for the preceding five days prior to the date of conversion.”